Beteiligungsmeldung

UBS Group AG

Declared position

13.247%

Threshold

Crossed upwards

Timeline

Published

21.11.2025

Transaction

14.11.2025

Voting rights breakdown

Erworbene Stimmrechte13.247%
Veräusserte Stimmrechte0.308%
Unter dem Schwellenwert0%

Notice details

KategorieSingle shareholder
BörseXSWX

Meldungs-ID

ZA01-000000000R710

Beneficial owner

UBS Group AG

Gemeldete Adresse

UBS Group AG, Zürich, CH

Crossing below 10% in voting rights (Section 4.1 and 4.2) ; In the recommendation of 14th July 2025, the Disclosure Office has exempted UBS Group AG with regard to equity securities in DocMorris AG from the reporting obligation pursuant to Art. 16 para. 2 in conjunction with Art. 22 para. 3 FinMIO-FINMA in the event of the addition or discontinuation of group companies completely controlled by it as direct participants. Accordingly, disclosure reports with regard to equity securities to DocMorris AG are required only if reporting obligations arise for other reasons. The Disclosure Office has granted this relief for a limited period until 2 August 2027. Any person or issuer may, without proof of interest, request UBS Group AG to inform in writing and free of charge, about the current direct participants within a period of two trading days. The inquiry should be sent to: UBS Group AG, Uetlibergstrasse 231, 8045 Zürich, Konstantina Georgaki, +41-44-239 40 71, sh-gsp-emea@ubs.com.

Diese Zahlen fassen öffentliche Meldungen zusammen. Sie stellen keine Anlageberatung dar.

Quelle: SIX Exchange Regulation

insider24.ch

Verpassen Sie kein Marktsignal mehr

Pro-AlarmeE-Mail und Telegram nach Veröffentlichung
Unbegrenzt Unternehmen verfolgenUnbegrenzte Watchlist mit dem Pro-Plan
MontagsrückblickDas Wichtigste zu Ihren Werten zur Eröffnung